News Digging > News > Rare blood disorders biotech Hemab raises $135M, begins trek into clinic
Rare blood disorders biotech Hemab raises 5M, begins trek into clinic
Rare blood disorders biotech Hemab raises $135M, begins trek into clinic,Hemab Therapeutics, led by Alnylam vet Benny Sorensen and chaired by John Maraganore, has raised $135 million from a new crop of investors as it begins pushing its blood disorder programs into the clinic. The raise gives Hemab a cash runway into 2025, and the biotech has a slate of

Rare blood disorders biotech Hemab raises $135M, begins trek into clinic

Hemab Therapeutics, led by Alnylam vet Benny Sorensen and chaired by John Maraganore, has raised $135 million from a new crop of investors as it begins pushing its blood disorder programs into the clinic. The raise gives Hemab a cash runway into 2025, and the biotech has a slate of